More about

Leukemia

News
July 11, 2022
2 min read
Save

Patients with blood cancers show immune response to COVID-19 vaccine boosters

Patients with blood cancers show immune response to COVID-19 vaccine boosters

Less than half of patients with hematologic malignances exhibited seroconversion after receiving their initial COVID-19 vaccine, research published in Cancer showed.

News
July 05, 2022
2 min read
Save

Childhood leukemia outcomes similar in patients with, without musculoskeletal disease

Childhood leukemia outcomes similar in patients with, without musculoskeletal disease

Childhood leukemia survival outcomes in patients with musculoskeletal involvement are similar to those among patients without musculoskeletal disease, according to data published in Pediatric Rheumatology.

News
June 30, 2022
3 min read
Save

Residence predictor of survival among Black, Hispanic patients with acute myeloid leukemia

Residence predictor of survival among Black, Hispanic patients with acute myeloid leukemia

Black and Hispanic patients with acute myeloid leukemia who resided in socially disadvantaged neighborhoods had a significantly greater risk for mortality than their white counterparts, according to study results published in Blood.

News
June 30, 2022
4 min read
Save

Death in hospice facility less common among rural vs. urban residents with blood cancer

Death in hospice facility less common among rural vs. urban residents with blood cancer

Patients with hematologic malignancies who resided in rural areas had a lower likelihood of death in a hospice facility but higher likelihood of dying in a nursing facility than their urban counterparts, according to study results.

News
June 29, 2022
7 min read
Save

Cancer cell therapy innovator shifts focus toward treatment of solid tumors

Cancer cell therapy innovator shifts focus toward treatment of solid tumors

Crystal L. Mackall, MD, believes she has an "unusual pedigree" for someone in her position.

News
June 24, 2022
4 min read
Save

Action plan aims to improve adherence to oral anticancer therapies

Action plan aims to improve adherence to oral anticancer therapies

Availability of oral anticancer medications has increased greatly during the past decade, offering patients the convenience of fewer appointments, less travel time and targeted treatment within the comfort of their homes.

News
June 21, 2022
2 min read
Save

Risk for maternal death higher in pregnancies complicated due to cancer

Risk for maternal death higher in pregnancies complicated due to cancer

Risks for severe maternal morbidity and mortality appeared higher among pregnancies complicated by cancer, according to study results in a research letter published in JAMA Oncology.

News
June 17, 2022
3 min read
Save

Quizartinib regimen extends survival vs. chemotherapy in acute myeloid leukemia subgroup

Quizartinib regimen extends survival vs. chemotherapy in acute myeloid leukemia subgroup

Adding quizartinib to standard chemotherapy and up to 3 years of continuation therapy extended OS among a subset of older adults with newly diagnosed acute myeloid leukemia, according to results of the phase 3 QuANTUM-First trial.

News
June 16, 2022
3 min read
Save

Time-limited venetoclax-based regimens prolong PFS vs. chemoimmunotherapy in CLL

Time-limited venetoclax-based regimens prolong PFS vs. chemoimmunotherapy in CLL

Time-limited venetoclax, obinutuzumab and ibrutinib or venetoclax plus obinutuzumab prolonged PFS compared with chemoimmunotherapy among fit, previously untreated patients with chronic lymphocytic leukemia, according to study results.

News
June 15, 2022
2 min read
Save

Decitabine ‘better-tolerated alternative’ to chemotherapy for older, fit patients with AML

Decitabine ‘better-tolerated alternative’ to chemotherapy for older, fit patients with AML

Older, fit patients with acute myeloid leukemia who received decitabine had transplant and survival rates comparable to those treated with induction chemotherapy but with fewer toxicities, according to results of a randomized phase 3 study.

View more